glp-1 for anxiety An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders GLP-1 diabetes drugs could stop
Description
Medicare coverage is expected to begin next year
Montgomery Purdue
They most commonly affect the gastrointestinal tract and occur especially during dose escalation
AEs: GLP-1 RAs showed a trend toward an increased risk of AEs across multiple populations
Dose adjustments happen in response to in-person evaluation, not a questionnaire
[DOI] [PubMed] [Google Scholar] 71.Rosen E.D., Spiegelman B.M
